| To date, the following organizations have provided educational grants in support of Primary Care Updates
Track 2: Forest Research Institute, a subsidiary of Forest Laboratories, Inc., and Ironwood Pharmaceuticals, Lilly USA, LLC, Merck and Vivus. |
| 7:00 AM-7:50 AM | Registration & Breakfast |
| 7:50 AM-8:00 AM | Opening Remarks |
| 8:00 AM-9:30 AM | Improving the Care of Patients with Chronic Pain: Individualized Assessment and Mechanism-Based Multimodal Treatment Learning Objectives: - Discuss the neurobiologic mechanisms that contribute to chronic pain and associated functional disability
- Assess biologic, psychological, and social factors that contribute to chronic pain via detailed patient histories, comprehensive clinical interviews, and targeted physical exams
- Prescribe and tailor pharmacologic regimens for chronic pain that reflect published evidence of efficacy, likely disease mechanisms, functional goals, and patient-specific risks of adverse outcomes
- Incorporate nonpharmacologic approaches and patient education to improve analgesia, functional gains, and treatment adherence
- Manage chronic pain in diverse patient populations, including older patients and patients with comorbid medical or psychiatric disorders
Bill McCarberg, MD (Read Bio), Adjunct Assistant Clinical Professor, University of California, San Diego, San Diego, CA, Founder, Chronic Pain Management Program, Kaiser Permanente, San Diego, CA, Family Practitioner, Neighborhood Health, San Diego, CA Steven Stanos, DO (Read Bio), Assistant Professor, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of Medicine, Chicago, IL, National Director, Corporate Pain Services, Attending Physician, Center for Pain Management, Rehabilitation Institute of Chicago, Chicago, IL Charles Argoff, MD, Professor of Neurology, Albany Medical College, Albany, NY, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY Improving the Care of Patients with Chronic Pain session meets the California state mandated CME requirement for 1.5 AMA PRA Category 1 Credit hours. |
| 9:30 AM-9:45 AM | AM Break |
| 9:45 AM-11:00 AM | Improving Adult Immunization Coverage in the US Learning Objectives: - Identify adult patients for appropriateness of administering vaccines based on current recommendations
- Act to increase provider recommendations to patients who should be vaccinated
- Implement standing orders for adult immunization within practice setting
William Schaffner, MD, Chairman, Department of Preventive Medicine, Professor of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN M. Susan Burke, MD, FACP (Read Bio), Clinical Assistant Professor of Medicine, Thomas Jefferson University, Philadelphia, PA Robert H. Hopkins, MD, FACP, FAAP, Professor of Internal Medicine and Pediatrics, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR |
| 11:00 AM-12:15 PM | Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic Learning Objectives: - Identify and evaluate patients with obesity by using parameters such as body mass index, waist circumference, and risk factor assessment
- Engage patients in open dialogues, highlighting the importance of lifestyle modification including decreased energy intake and exercise as part of a healthy lifestyle
- Confidently utilize pharmacologic agents to reinforce lifestyle change for patients with obesity and obesity-related comorbid conditions
Michelle Look, MD, FAAFP, Family Practice-Sports Medicine Physician, San Diego Sports Medicine and Family Health Center, San Diego, CA Holly R. Wyatt, MD (Read Bio), Associate Professor of Medicine, Division of Endocrine, Metabolism, and Diabetes, Associate Director, Anschutz Health and Wellness Center, University of Colorado Denver, Denver, CO |
| 12:15 PM-1:00 PM | Lunch |
| 1:00 PM-2:30 PM | Insulin Replacement Therapy for Type 2 Diabetes: Patient-Centered Management of Hyperglycemia in Primary Care Learning Objectives: - Discuss the multisystem consequences of T2DM and the rationale for appropriate screening, early diagnosis, and prompt treatment
- Establish individualized treatment goals for patients with T2DM according to disease duration, age, comorbidities, and ongoing evaluations of hemoglobin A1C, blood glucose profiles, and therapeutic responses
- Employ evidence-based frameworks and new treatment approaches to individualize basal and mealtime insulin therapies across diverse T2DM patient populations
- Integrate patient-specific clinical and psychosocial factors into comprehensive treatment plans that include lifestyle modifications and pharmacologic interventions for T2DM
- Educate patients with T2DM about the importance of treatment adherence and the risks of insulin-related hypoglycemia
Jeff Unger, MD, FAAFP, Assistant Professor of Family Medicine, Loma Linda University School of Medicine, Riverside, CA, Director, Metabolic Studies, Catalina Research Institute, Chino, CA Mark W. Stolar, MD, Associate Professor of Clinical Medicine, Northwestern University Medical School, Chicago, IL Derek LeRoith, MD, PhD, Director of Research, Professor of Medicine, Division of Endocrinology, Mount Sinai School of Medicine, New York, NY |
| 2:30 PM-2:45 PM | PM Break |
| 2:45 PM-4:00 PM | Under Pressure: The Need to Expedite IBS Diagnosis and Treatment in Primary Care Learning Objectives: - Diagnose IBS based upon symptoms that may be shared with other functional gastrointestinal disorders or organic diseases
- Compare and contrast the efficacy and safety of available pharmacologic and non-pharmacologic treatment options for IBS
- Apply appropriate and comprehensive treatment strategies to enhance the care of patients with IBS
Lawrence R. Schiller, MD, FACS (Read Bio), Professor of Internal Medicine, Texas A&M Health Science Center, Dallas Campus, Dallas, TX, Program Director, Gastroenterology Fellowship, Baylor University Medical Center, Dallas, TX Brian E. Lacy, MD, PhD (Read Bio), Professor of Medicine, Dartmouth Medical School, Lebanon, NH, Director of the GI Motility Laboratory, Dartmouth Hitchcock Medical Center, Lebanon, NH |